SCHEMBL6072275

SCHEMBL6072275

CCOC(=O)CCc1ccc(C2=NC(C)(C)Cc3cc(OCC)c4c(c32)CC(C)(C)O4)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 1/20 0.36
CYP4A11 Q02928 1/20 0.36
SYK P43405 4/20 0.35
HRH3 Q9Y5N1 1/20 0.34
MAPT P10636 3/20 0.33
KMT2A Q03164 3/20 0.33
TSHR P16473 1/20 0.33
HBB P68871 1/20 0.33
ALDH1A1 P00352 3/20 0.33
KDM4E B2RXH2 2/20 0.33
HPGD P15428 2/20 0.33
FFAR4 Q5NUL3 2/20 0.33
GAA P10253 1/20 0.33
CASP1 P29466 1/20 0.33
HSD17B10 Q99714 1/20 0.33
MEN1 O00255 1/20 0.32
XBP1 P17861 1/20 0.32
PDE3B Q13370 1/20 0.32
PDE3A Q14432 1/20 0.32
P2RY12 Q9H244 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6072465 0.91 SSTR5 (0.39) MAPTFFAR4POLBSSTR5
SCHEMBL6072329 0.86 ALDH1A1 (0.35) MAPTKMT2ATSHRHBBALDH1A1
SCHEMBL6071737 0.86 SSTR5 (0.41) MAPTALDH1A1KDM4EFFAR4SSTR5
SCHEMBL5785108 0.84 FFAR4 (0.35) MAPTKMT2AALDH1A1KDM4EHPGD
SCHEMBL6071475 0.84 NPC1 (0.39) MAPTKMT2ATSHRHBBALDH1A1
Hydrochloric Acid SCHEMBL5785102 0.84 FFAR4 (0.35) MAPTKMT2AALDH1A1KDM4EHPGD
SCHEMBL6071725 0.83 FFAR4 (0.33) HRH3KMT2AALDH1A1KDM4EHPGD
Hydrochloric Acid SCHEMBL6072633 0.83 KDM4E (0.35) KMT2ATSHRHBBALDH1A1KDM4E
SCHEMBL5783270 0.82 MAPT (0.37) MAPTKMT2ATSHRALDH1A1FFAR4
Hydrochloric Acid SCHEMBL6071935 0.82 SSTR5 (0.34) HRH3ALDH1A1KDM4EHPGDFFAR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060106048-A1 Furoisoquinoline derivative and use thereof PASCALI, PETROS P. (CY) 2006-05-18 US disclosed
EP-1541576-A1 FUROISOQUINOLINE DERIVATIVE AND USE THEREOF Takeda Pharmaceutical Company Limited (JP) 2005-06-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060106048-A1 Furoisoquinoline derivative and use thereof PDE3B, PDE2A, PDE3A CYP4F2 116/4885CYP4A11 41/4885SYK 467/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.